Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Antitumor Activity of Lentivirus-mediated Interleukin -12 Gene Modified Dendritic Cells in Human Lung Cancer in Vitro

  • Ali, Hassan Abdellah Ahmed (Department of Central Research, Second Hospital, Jilin University) ;
  • Di, Jun (Department of Central Research, Second Hospital, Jilin University) ;
  • Mei, Wu (Department of Central Research, China-Japan Union Hospital, Jilin University) ;
  • Zhang, Yu-Cheng (Department of Central Research, China-Japan Union Hospital, Jilin University) ;
  • Li, Yi (Department of Immunology, Norman Bethune College, Jilin University) ;
  • Du, Zhen-Wu (Department of Central Research, Second Hospital, Jilin University) ;
  • Zhang, Gui-Zhen (Department of Central Research, Second Hospital, Jilin University)
  • Published : 2014.01.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: Dendritic cell (DC)-based tumor immunotherapy needs an immunogenic tumor associated antigen (TAA) and an effective approach for its presentation to lymphocytes. In this study we explored whether transduction of DCs with lentiviruses (LVs) expressing the human interleukin-12 gene could stimulate antigen-specific cytotoxic T cells (CTLs) against human lung cancer cells in vitro. Methods: Peripheral blood monocyte-derived DCs were transduced with a lentiviral vector encoding human IL-12 gene (LV-12). The anticipated target of the human IL-12 gene was detected by RT-PCR. The concentration of IL-12 in the culture supernatant of DCs was measured by ELISA.Transduction efficiencies and CD83 phenotypes of DCs were assessed by flow cytometry. DCs were pulsed with tumor antigen of lung cancer cells (DC+Ag) and transduced with LV-12 (DC-LV-12+Ag). Stimulation of T lymphocyte proliferation by DCs and activation of cytotoxic T-lymphocytes (CTL) stimulated by LV-12 transduced DCs pulsed with tumor antigen against A549 lung cancer cells were assessed with methyl thiazolyltetrazolium (MTT). Results: A recombinant lentivirus expressing the IL-12 gene was successfully constructed. DC transduced with LV-12 produced higher levels of IL-12 and expressed higher levels of CD83 than non-transduced. The DC modified by interleukin -12 gene and pulsed with tumor antigen demonstrated good stimulation of lymphocyte proliferation, induction of antigen-specific cytotoxic T lymphocytes and antitumor effects. Conclusions: Dendritic cells transduced with a lentivirus-mediated interleukin-12 gene have an enhanced ability to kill lung cancer cells through promoting T lymphocyte proliferation and cytotoxicity.

Keywords

References

  1. Coca S, Enrech S, Moreno Garcia V, et al (2005). Evaluation of the antitumor activity of interleukin-12 in an experimental murine model of colorectal cancer induced by 1, 2 dimethylhydrazine (DMH). Rev Esp Enferm Dig, 97, 619-28.
  2. Cranmer LD, Trevor KT Hersh EM (2004). Clinical applications of dendritic cell vaccination in the treatment of cancer. Cancer Immunol Immunother, 53, 275-306. https://doi.org/10.1007/s00262-003-0432-5
  3. Dullaers M, Van Meirvenne S, Heirman C, et al (2006). Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors. Gene Ther, 13, 630-40. https://doi.org/10.1038/sj.gt.3302697
  4. Fuss IJ, Kanof ME, Smith PD Zola H (2009). Isolation of whole mononuclear cells from peripheral blood and cord blood. Curr Protoc Immunol Chapter, 7, Unit7 1.
  5. Garg NK, Dwivedi P, Prabha P Tyagi RK (2013). RNA pulsed dendritic cells: an approach for cancer immunotherapy. Vaccine, 31, 1141-56. https://doi.org/10.1016/j.vaccine.2012.12.027
  6. Gately MK, Desai BB, Wolitzky AG, et al (1991). Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol, 147, 874-82.
  7. Gherardi MM, Ramirez JC Esteban M (2000). Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: suppressive effects of IL-12 boost are mediated by nitric oxide. J Virol, 74, 6278-86. https://doi.org/10.1128/JVI.74.14.6278-6286.2000
  8. Guermonprez P, Valladeau J, Zitvogel L, Thery C Amigorena S (2002). Antigen presentation and T cell stimulation by dendritic cells. Annu Rev Immunol, 20, 621-67. https://doi.org/10.1146/annurev.immunol.20.100301.064828
  9. Han B, Zhong H, Fan X, et al (2006). [A primary study of immunotherapy with carcinoembryonic antigen peptidepulsed, autologous human cultured dendritic cells in patients with advanced non-small cell lung cancer]. Zhongguo Fei Ai Za Zhi, 9, 340-4.
  10. Hansen M, Hjorto GM, Donia M, et al (2013). Comparison of clinical grade type 1 polarized and standard matured dendritic cells for cancer immunotherapy. Vaccine, 31, 639-46. https://doi.org/10.1016/j.vaccine.2012.11.053
  11. Hwang EC, Lim MS, Im CM, et al (2013). Generation of potent cytotoxic T lymphocytes against castration-resistant prostate cancer cells by dendritic cells loaded with dying allogeneic prostate cancer cells. Scand J Immunol, 77, 117-24. https://doi.org/10.1111/sji.12007
  12. Janeway CA, Jr. Medzhitov R (2002). Innate immune recognition. Annu Rev Immunol, 20, 197-216. https://doi.org/10.1146/annurev.immunol.20.083001.084359
  13. Kaech SM Ahmed R (2003). Immunology. CD8 T cells remember with a little help. Science, 300, 263-5. https://doi.org/10.1126/science.1084511
  14. Kikuchi T, Akasaki Y, Irie M, et al (2001). Results of a phase I clinical trial of vaccination of glioma patients with fusions of dendritic and glioma cells. Cancer Immunol Immunother, 50, 337-44. https://doi.org/10.1007/s002620100205
  15. Koutsokera A, Kiagia M, Saif MW, Souliotis K Syrigos KN (2013). Nutrition Habits, Physical Activity, and Lung Cancer: An Authoritative Review. Clin Lung Cancer, 14, 342-50. https://doi.org/10.1016/j.cllc.2012.12.002
  16. Lesterhuis WJ, de Vries IJ, Adema GJ Punt CJ (2004). Dendritic cell-based vaccines in cancer immunotherapy: an update on clinical and immunological results. Ann Oncol, 15 Suppl 4, iv145-51.
  17. Li R, Zheng X, Popov I, et al (2012). Gene silencing of IL-12 in dendritic cells inhibits autoimmune arthritis. J Transl Med, 10, 19. https://doi.org/10.1186/1479-5876-10-19
  18. Marten A, Renoth S, Heinicke T, et al (2003). Allogeneic dendritic cells fused with tumor cells: preclinical results and outcome of a clinical phase I/II trial in patients with metastatic renal cell carcinoma. Hum Gene Ther, 14, 483-94. https://doi.org/10.1089/104303403321467243
  19. Mehrotra PT, Wu D, Crim JA, Mostowski HS Siegel JP (1993). Effects of IL-12 on the generation of cytotoxic activity in human CD8+ T lymphocytes. J Immunol, 151, 2444-52.
  20. Nouri-Shirazi M, Banchereau J, Fay J Palucka K (2000). Dendritic cell based tumor vaccines. Immunol Lett, 74, 5-10. https://doi.org/10.1016/S0165-2478(00)00243-1
  21. Perroud MW, Jr., Honma HN, Barbeiro AS, et al (2011). Mature autologous dendritic cell vaccines in advanced non-small cell lung cancer: a phase I pilot study. J Exp Clin Cancer Res, 30, 65. https://doi.org/10.1186/1756-9966-30-65
  22. Picanco-Castro V, de Sousa Russo-Carbolante EM Tadeu Covas D (2012). Advances in lentiviral vectors: a patent review. Recent Pat DNA Gene Seq, 6, 82-90. https://doi.org/10.2174/187221512801327433
  23. Portielje JE, Gratama JW, van Ojik HH, Stoter G Kruit WH (2003). IL-12: a promising adjuvant for cancer vaccination. Cancer Immunol Immunother, 52, 133-44.
  24. Ragde H, Cavanagh WA Tjoa BA (2004). Dendritic cell based vaccines: progress in immunotherapy studies for prostate cancer. J Urol, 172, 2532-8. https://doi.org/10.1097/01.ju.0000144211.51111.e4
  25. Schuler G Romani N (1997). Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. Adv Exp Med Biol, 417, 7-13. https://doi.org/10.1007/978-1-4757-9966-8_2
  26. Seggewiss R Dunbar CE (2005). A new direction for gene therapy: intrathymic T cell-specific lentiviral gene transfer. J Clin Invest, 115, 2064-7. https://doi.org/10.1172/JCI26041
  27. Song Z, Guo C, Li Y, et al (2012). Enhanced antitumor effects of a dendritic cell vaccine transfected with gastric cancer cell total RNA carrying the 4-1BBL gene in vitro. Exp Ther Med, 3, 319-23.
  28. Tamandani DM, Shekari M Suri V (2009). Interleukin-12 gene polymorphism and cervical cancer risk. Am J Clin Oncol, 32, 524-528. https://doi.org/10.1097/COC.0b013e318192519a
  29. Vannucci L, Lai M, Chiuppesi F, Ceccherini-Nelli L Pistello M (2013). Viral vectors: a look back and ahead on gene transfer technology. New Microbiol, 36, 1-22.
  30. Wang J, Zou ZH, Xia HL, et al (2012). Strengths and weaknesses of immunotherapy for advanced non-small-cell lung cancer: a meta-analysis of 12 randomized controlled trials. PLoS One, 7, e32695. https://doi.org/10.1371/journal.pone.0032695

Cited by

  1. MAGED4 Expression in Glioma and Upregulation in Glioma Cell Lines with 5-Aza-2'-Deoxycytidine Treatment vol.15, pp.8, 2014, https://doi.org/10.7314/APJCP.2014.15.8.3495
  2. 5-Fluorouracil and Interleukin-2 Immunochemotherapy Enhances Immunogenicity of Non-Small Cell Lung Cancer A549 Cells through Upregulation of NKG2D Ligands vol.15, pp.9, 2014, https://doi.org/10.7314/APJCP.2014.15.9.4039
  3. Adoptive Immunotherapy for Small Cell Lung Cancer by Expanded Activated Autologous Lymphocytes: a Retrospective Clinical Analysis vol.16, pp.4, 2015, https://doi.org/10.7314/APJCP.2015.16.4.1487
  4. Tumor-derived CD4+CD25+ Tregs Inhibit the Maturation and Antigen-Presenting Function of Dendritic Cells vol.16, pp.7, 2015, https://doi.org/10.7314/APJCP.2015.16.7.2665
  5. Mucin 1 and poly I:C activates dendritic cells and effectively eradicates pituitary tumors as a prophylactic vaccine vol.13, pp.4, 2016, https://doi.org/10.3892/mmr.2016.4964
  6. Viral gene therapy for breast cancer: progress and challenges vol.17, pp.8, 2017, https://doi.org/10.1080/14712598.2017.1338684
  7. The transduction pattern of IL-12-encoding lentiviral vectors shapes the immunological outcome vol.45, pp.12, 2015, https://doi.org/10.1002/eji.201545559
  8. K9(C4H4FN2O2)2Nd(PW11O39)2·25H2O induces apoptosis in human lung cancer A549 cells vol.13, pp.3, 2016, https://doi.org/10.3892/ol.2016.5543
  9. SYK-targeted dendritic cell-mediated cytotoxic T lymphocytes enhance the effect of immunotherapy on retinoblastoma vol.144, pp.4, 2018, https://doi.org/10.1007/s00432-018-2584-x